NeuroSense Therapeutics
NRSN
NRSN
5 hedge funds and large institutions have $243K invested in NeuroSense Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
$193K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
$20.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$8.19K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
$0 |
| 2 |
Morgan Stanley
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $193K | +$193K | +95,000 | New |
|
|
GSC
2
Ground Swell Capital
Folly Beach,
South Carolina
| $20.6K | +$20.6K | +11,858 | New |
|
|
VPIM
3
Vanguard Personalized Indexing Management
Oakland,
California
| $19.3K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $8.19K | +$1.2K | +697 | +17% |
|
5
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $2K | – | – | – |
|
|
6
Renaissance Technologies
New York
| – | -$22K | -18,433 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$5 | -4 | Closed |
|